[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-572405-105":53,"doc-detail-572405-en":120},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":113,"head_meta":115,"extra_data":117,"updated_unix":119},105,"en","abim-laboratory-test-reference-ranges-january-2026","ABIM Laboratory Test Reference Ranges - January 2026","","Comprehensive laboratory test reference ranges for clinical interpretation, organized alphabetically by analyte and specimen type (serum, plasma, urine, whole blood, or specified conditions). Includes gender- and physiologic-state-specific cutoffs (e.g., female follicular/luteal/postmenopausal), qualitative thresholds (negative/borderline/positive), and ranges for hematologic and biochemical markers. Provides unit-specific limits for endocrine, immune, coagulation, renal, hepatic, metabolic, and blood gas parameters to support standardized result comparison.",{"@graph":63,"@context":112},[64,80,95],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":36,"@type":70,"position":76},"https://docshare.wps.com/template/forms/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/abim-laboratory-test-reference-ranges-january-2026/572405/",4,{"url":78,"name":59,"@type":81,"author":82,"headline":59,"publisher":85,"fileFormat":88,"inLanguage":57,"description":61,"dateModified":89,"datePublished":89,"encodingFormat":88,"isAccessibleForFree":90,"interactionStatistic":91},"DigitalDocument",{"name":83,"@type":84},"RuangKosong","Person",{"url":68,"name":86,"@type":87},"DocShare","Organization","application/pdf","2026-10-13",true,{"@type":92,"interactionType":93,"userInteractionCount":4},"InteractionCounter",{"@type":94},"ViewAction",{"@type":96,"mainEntity":97},"FAQPage",[98,104,108],{"name":99,"@type":100,"acceptedAnswer":101},"What does the document provide for each laboratory test?","Question",{"text":102,"@type":103},"It lists reference ranges for each laboratory test, specifying the specimen type and the expected normal interval or cutoff.","Answer",{"name":105,"@type":100,"acceptedAnswer":106},"Do the reference ranges vary by sex or physiological state?",{"text":107,"@type":103},"Yes. Many analytes include different limits for female vs male and for states such as follicular, luteal, or postmenopausal.",{"name":109,"@type":100,"acceptedAnswer":110},"Are there tests with negative/borderline/positive categories?",{"text":111,"@type":103},"Yes. Some immunologic assays provide interpretive categories such as negative, borderline, and positive thresholds.","https://schema.org",{"og:url":78,"og:type":114,"og:title":59,"og:site_name":86,"og:description":61},"article",{"robots":116,"canonical":78},"index,follow",{"doc_id":118,"site_id":56},572405,1791927244,{"code":4,"msg":5,"data":121},{"doc_id":118,"user_id":122,"nickname":83,"user_avatar":123,"doc_module":9,"category_id":35,"category_name":36,"doc_title":59,"doc_description":61,"doc_content":124,"file_id":125,"file_url":126,"file_type":127,"file_size":128,"view_count":4,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":15,"language":129,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":130,"faqs":131,"seo_title":132,"seo_description":61,"update_tm":119,"read_time":79},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","| |  |\n| --- | --- |\n| ABIM Laboratory Test Reference Ranges ̶ January 2026 |  |\n| Laboratory Tests | Reference Ranges |\n| 1,25-Dihydroxyvitamin D\u003Cbr>(1,25-dihydroxycholecalciferol), serum | See Vitamin D metabolites |\n| 1,5-Anhydroglucitol, serum or plasma | Female: 6.8–29.3 μg/mL; male: 10.7–32 μg/mL |\n| 17-Hydroxycorticosteroids (Porter-Silber), urine | Female: 2–8 mg/24 hr; male: 3–10 mg/24 hr |\n| 17-Hydroxyprogesterone, serum |  |\n| Female, follicular | ˂80 ng/dL |\n| Female, luteal | ˂285 ng/dL |\n| Female, postmenopausal | ˂51 ng/dL |\n| Male (adult) | ˂220 ng/dL |\n| 25-Hydroxyvitamin D\u003Cbr>(25-hydroxycholecalciferol), serum | See Vitamin D metabolites |\n| 5-Hydroxyindoleacetic acid, urine | 2–9 mg/24 hr |\n| 5'-Nucleotidase, serum | 0.3–2.6 (Bodansky) units/dL (0–15 U/L) |\n| 6-Thioguanine, whole blood | 230–400 pmol/8x108 RBCs |\n| Absolute basophil count | 0–110/μL |\n| Absolute eosinophil count | 0–330/μL |\n| Absolute lymphocyte count | 1200–4950/μL |\n| Absolute monocyte count | 0–660/μL |\n| Absolute neutrophil count (ANC) | 2000–8250/μL |\n| Acid phosphatase, serum |  |\n| Total | 0.5–2.0 (Bodansky) units/mL |\n| Prostatic fraction | 0.1–0.4 unit/mL |\n| ACTH, plasma | 10–60 pg/mL |\n| Activated partial thromboplastin time | 25–35 seconds |\n| ADAMTS13 activity | >60% |\n| Adrenocorticotropic hormone (ACTH), plasma | 10–60 pg/mL |\n| Albumin, serum | 3.5–5.5 g/dL |\n| Albumin, urine | ˂25 mg/24 hr |\n| Albumin-to-creatinine ratio, urine | ˂30 mg/g |\n| Aldolase, serum | 0.8–3.0 IU/mL |\n| Aldosterone, plasma |  |\n| Supine or seated | ≤10 ng/dL |\n| Standing | ˂21 ng/dL |\n| Low-sodium diet (supine) | ≤30 ng/dL |\n| Aldosterone, urine | 5–19 μg/24 hr |\n| Alkaline phosphatase, serum | 30–120 U/L |\n| Alpha1-antitrypsin (AAT), serum | 150–350 mg/dL |\n| Alpha2-antiplasmin activity, plasma | 75%–115% |\n| Alpha-amino nitrogen, urine | 100–290 mg/24 hr |\n| Alpha-fetoprotein, serum | ˂10 ng/mL |\n| Amino acids, urine | 200–400 mg/24 hr |\n| Aminotransferase, serum alanine (ALT, SGPT) | 10–40 U/L |\n| Aminotransferase, serum aspartate (AST, SGOT) | 10–40 U/L |\n| Ammonia, plasma | 40–70 μg/dL |\n| Amylase, serum | 25–125 U/L (80–180 [Somogyi] units/dL) |\n\n\n| Amylase, urine | 1–17 U/hr |\n| --- | --- |\n| Androstenedione, serum | Female: 30–200 ng/dL; male: 40–150 ng/dL |\n| Angiotensin-converting enzyme, serum | 8–53 U/L |\n| Anion gap, serum | 7–13 mEq/L |\n| Antibodies to double-stranded DNA | 0–7 IU/mL |\n| Anticardiolipin antibodies |  |\n| IgG | ˂20 GPL |\n| IgM | ˂20 MPL |\n| Anti-cyclic citrullinated peptide antibodies | ˂20 units |\n| Antideoxyribonuclease B | ˂280 units |\n| Anti-F-actin antibodies, serum | ≤1:80 |\n| Antihistone antibodies | ˂1:16 |\n| Anti-liver-kidney microsomal antibodies (anti-LKM) | ˂1:20 |\n| Antimitochondrial antibodies | ≤1:5 |\n| Anti–myelin associated glycoprotein antibody | ˂1:1600 |\n| Antimyeloperoxidase antibodies | ˂1 .0 U |\n| Antinuclear antibodies | ≤1:40 |\n| Anti-phospholipase A2 receptor (PLA2R) antibodies, serum\u003Cbr>[ELISA] | Negative: \u003C14 RU/mL\u003Cbr>Borderline: 14 – \u003C20 RU/mL\u003Cbr>Positive: ≥20 RU/mL |\n| Anti-RNP antibodies\u003Cbr>[by chemiluminescence method] | \u003C20 CU |\n| Anti-RNP antibodies\u003Cbr>[by multiplex flow immunoassay] | \u003C1 .0 AI |\n| Anti-Scl-70 antibodies (topoisomerase 1 antibodies), IgG, serum | Negative: \u003C1.0 U\u003Cbr>[Positive: ≥1 .0 U] |\n| Anti–smooth muscle antibodies | ≤1:80 |\n| Anti-SSA/Ro & anti-SSB antibodies\u003Cbr>[by chemiluminescence method] | \u003C20 CU |\n| Anti-SSA/Ro & anti-SSB antibodies\u003Cbr>[by multiplex flow immunoassay] | \u003C1 .0 AI |\n| Antistreptolysin O titer | ˂200 Todd units |\n| Antithrombin activity | 80%–120% |\n| Antithyroglobulin antibodies | ˂20 U/mL |\n| Antithyroid peroxidase antibodies | ˂2 .0 U/mL |\n| Anti-tissue transglutaminase antibodies | See Tissue transglutaminase antibody |\n| Apolipoprotein A-1, serum | Female: ≥140 mg/dL\u003Cbr>Male: ≥120 mg/dL |\n| Apolipoprotein B, serum | Desirable: ˂90 mg/dL\u003Cbr>Borderline high: 90–119 mg/dL\u003Cbr>High: 120–139 mg/dL\u003Cbr>Very High: ≥140 mg/dL |\n| Arterial blood gas stu","cbCaij0gehAhhWiZ","https://ap.wps.com/l/cbCaij0gehAhhWiZ","pdf",899832,"English","# Laboratory Tests\n## Reference Ranges","[{\"question\":\"What does the document provide for each laboratory test?\",\"answer\":\"It lists reference ranges for each laboratory test, specifying the specimen type and the expected normal interval or cutoff.\"},{\"question\":\"Do the reference ranges vary by sex or physiological state?\",\"answer\":\"Yes. Many analytes include different limits for female vs male and for states such as follicular, luteal, or postmenopausal.\"},{\"question\":\"Are there tests with negative/borderline/positive categories?\",\"answer\":\"Yes. Some immunologic assays provide interpretive categories such as negative, borderline, and positive thresholds.\"}]","ABIM Laboratory Test Reference Ranges - January 2026 | PDF"]